BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12452863)

  • 1. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients.
    Dereure O; Raison-Peyron N; Larrey D; Blanc F; Guilhou JJ
    Br J Dermatol; 2002 Dec; 147(6):1142-6. PubMed ID: 12452863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.
    Hashimoto Y; Kanto H; Itoh M
    J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Generalized eczema secondary to combined treatment with peginterferon alfa-2a and ribavirin in a patient with chronic hepatitis from the hepatitis C virus].
    Ruiz de Casas A; García-Bravo B; Camacho F
    Actas Dermosifiliogr; 2005 Mar; 96(2):122-3. PubMed ID: 16476350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
    Moore MM; Elpern DJ; Carter DJ
    Arch Dermatol; 2004 Feb; 140(2):215-7. PubMed ID: 14967798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases.
    Cogrel O; Doutre MS; Marlière V; Beylot-Barry M; Couzigou P; Beylot C
    Br J Dermatol; 2002 Feb; 146(2):320-4. PubMed ID: 11903249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment.
    Vázquez-López F; Manjón-Haces JA; Pérez-Alvarez R; Pérez-Oliva N
    Br J Dermatol; 2004 May; 150(5):1046-7; author reply 1047. PubMed ID: 15149535
    [No Abstract]   [Full Text] [Related]  

  • 8. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 9. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus.
    Sookoian S; Neglia V; Castaño G; Frider B; Kien MC; Chohuela E
    Arch Dermatol; 1999 Aug; 135(8):1000-1. PubMed ID: 10456365
    [No Abstract]   [Full Text] [Related]  

  • 10. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
    Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
    Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin.
    Kerl K; Negro F; Lübbe J
    Br J Dermatol; 2003 Sep; 149(3):656. PubMed ID: 14511009
    [No Abstract]   [Full Text] [Related]  

  • 12. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.
    Wendling J; Descamps V; Grossin M; Marcellin P; Le Bozec P; Belaich S; Crickx B
    Arch Dermatol; 2002 Apr; 138(4):546-7. PubMed ID: 11939833
    [No Abstract]   [Full Text] [Related]  

  • 13. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
    Hurst EA; Mauro T
    Arch Dermatol; 2005 Jul; 141(7):865-8. PubMed ID: 16027302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
    Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
    Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
    [No Abstract]   [Full Text] [Related]  

  • 15. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C.
    Tavakoli-Tabasi S; Bagree A
    J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous reactions in patients with chronic hepatitis C treated with peginterferon and ribavirin.
    Patrk I; Morović M; Markulin A; Patrk J
    Dermatology; 2014; 228(1):42-6. PubMed ID: 24434490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection.
    Tsilika K; Tran A; Trucchi R; Pop S; Anty R; Cardot-Leccia N; Lacour JP; Ortonne JP; Passeron T
    JAMA Dermatol; 2013 Jun; 149(6):675-7. PubMed ID: 23553009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous adverse events of telaprevir/peginterferon/ribavirin therapy for chronic hepatitis C: A multicenter prospective cohort study].
    Lorcy S; Gaudy-Marqueste C; Botta D; Portal I; Quiles N; Oulies V; Mancini J; Grob JJ; Richard MA
    Ann Dermatol Venereol; 2016 May; 143(5):336-46. PubMed ID: 27161648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.